{"disease":{"id":"giant-cell-tumors","name":"giant cell tumors"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00680992","title":"Study of Denosumab in Subjects With Giant Cell Tumor of Bone","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":535,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT02948088","title":"Tenosynovial Giant Cell Tumors (TGCT) Observational Platform Project","phase":"","overall_status":"COMPLETED","enrollment_count":183,"lead_sponsor_name":"Daiichi Sankyo","has_results":true},{"nct_id":"NCT06331104","title":"Network Pharmacology Prediction: Mechanism Study of Puerarin in the Treatment of Giant Cell Tumors of Bone","phase":"","overall_status":"COMPLETED","enrollment_count":145,"lead_sponsor_name":"Changye Zou","has_results":false},{"nct_id":"NCT02371369","title":"Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Daiichi Sankyo","has_results":true},{"nct_id":"NCT05542524","title":"Oral Care of Patients Treated With Anti-RANK-ligand Antibodies for a Giant Cell Tumour","phase":"","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}